Maeve Conneighton | IR, Argot Partners |
Dan Swisher | President and CEO |
Judy Fox | Chief Scientific Officer |
Par Hyare | VP, Global Oncology Operations |
Eric Schmidt | Cowen & Company |
Nick Abbott | Wells Fargo |
Mara Goldstein | Cantor Fitzgerald |
Nathaniel Calloway | Edison Group |
Good day, ladies and gentlemen, and welcome to the Sunesis Pharmaceuticals Q3 2017 Financial Results and Recent Highlights Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to introduce your host for today’s call, Maeve Conneighton, Investor Relations with Argot Partners.